4H-1-Benzopyran-4-one, 5-hydroxy-8-[5-[5-hydroxy-4-oxo-7-(phosphonooxy)-4H-1-benzopyran-2-yl]-2-methoxyphenyl]-2-(4-methoxyphenyl)-7-(phosphonooxy)-, sodium salt (1:4)
IP2 is an immunomodulator; it enhances PTP-derived antigen presentation in cancer cells, exhibits no cytotoxicity toward cancer cells, and induces tumor growth impairment in mice.